CoChat

Efficacy and Safety of Acupuncture and Acupuncture-Combined Therapies in the Treatment of Sciatica Caused by Lumbar Disc Herniation: A Network Meta-Analysis

Open access
Ni, Dongyi, Tong, Haiyang, Wei, Shen, Zheng, Yitong, Wu, Wenyan, Li, Min, Dong, Yunpeng · 2025 · Journal of Pain Research

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 8 of the 12 sources its claims cite were checked for support.

Abstract

Purpose: Sciatica is a common complication of lumbar disc herniation (LDH). This network meta-analysis compared the efficacy of acupuncture monotherapies, acupuncture versus conventional rehabilitation, and acupuncture monotherapy versus combination therapies for LDH-related sciatica. Patients and Methods: We systematically searched PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wanfang, CQVIP, and CBM. Bayesian network meta-analysis was performed using RStudio and GEMTC. STATA generated network and funnel plots. Treatment rankings were assessed using the Surface Under the Cumulative Ranking curve (SUCRA). Bias risk was evaluated with the Cochrane Risk of Bias tool 2.0. Results: According to SUCRA, in terms of total effective rate, the more effective intervention was electroacupuncture combined with cupping therapy (EA+Cupping, 92.93%); in terms of VAS, the better intervention was needle knife combined with rehabilitation therapy (NK+RT, 95.96%); in terms of ODI, the more effective intervention was electroacupuncture combined with cupping therapy (EA+Cupping, 98.03%); in terms of JOA, the best intervention was electrostimulation combined with rehabilitation therapy (ES+RT, 88.27%); in terms of IL-6 and TNF-α, the better intervention was electroacupuncture combined with electrostimulation (EA+ES, 99.99%). Conclusion: Acupuncture combined with other therapies demonstrates superior efficacy compared to rehabilitation treatment. Specifically, NK+RT is possibly a more effective intervention for pain relief; EA+Cupping shows a better benefit in improving disability and quality of life; ES+RT is likely a more effective strategy for promoting neurological recovery; and EA+ES is possibly better in reducing inflammatory responses.

Overview

CoChat Summary

TL;DR

This PRISMA-registered network meta-analysis of 94 RCTs (6928 patients) compared acupuncture monotherapies and acupuncture-combined therapies for sciatica caused by lumbar disc herniation. The most favorable ranked interventions varied by outcome: NK+RT for pain, EA+Cupping for disability, ES+RT for neurological recovery, and EA+ES for inflammatory markers.

Key findings

  • The review included 94 studies from China and South Korea with 6928 patients; 40 studies were rated low risk of bias and 54 moderate risk, with none high risk.
  • For total effective rate, EA+Cupping had the highest SUCRA (92.93%), and several interventions improved total effective rate versus RT, including NK+RT (MD = 1.67, 95% CrI 1.34–2.17) and EA+Cupping (MD = 1.58, 95% CrI 1.38–1.83).
  • For VAS, NK+RT ranked best (95.96%); compared with RT, NK+RT reduced VAS (MD = −3.30, 95% CrI −3.72 to −2.89), while ES+RT also reduced VAS (MD = −1.26, 95% CrI −1.45 to −1.07).
  • For ODI, EA+Cupping ranked best (98.03%) and improved disability versus RT (MD = −9.08, 95% CrI −15.38 to −2.80); for JOA, ES+RT ranked best (88.27%) and improved scores versus RT (MD = 5.16, 95% CrI 4.67–5.65). For IL-6 and TNF-α, EA+ES ranked best (99.99% for both) and showed the largest reductions versus MA (IL-6 MD = −49.88; TNF-α MD = −49.90).

Methods

  • Systematic review and Bayesian network meta-analysis of randomized controlled trials on patients with sciatica caused by lumbar disc herniation; protocol registered in PROSPERO (CRD420250647816) and conducted per PRISMA/NMA guidance.
  • Searched 8 databases (PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wanfang, CQVIP, CBM) from inception to February 10, 2025, limited to English or Chinese.
  • Main analyses used RStudio/GEMTC (Bayesian MCMC, SUCRA ranking, node-splitting inconsistency checks) and STATA for network/funnel plots; outcomes included total effective rate, VAS, ODI, JOA, IL-6, TNF-α, and adverse events.

Limitations

  • The paper states that blinding was difficult, most studies lacked detailed blinding/allocation concealment, some interventions had only a limited number of studies, direct vs indirect discrepancies appeared for several outcomes, key clinical variables were not stratified (eg, surgical status, acute vs chronic symptoms, comorbidities), and heterogeneity remained high for some outcomes.
  • The text also makes evident that the evidence base is largely Chinese and includes many trials with moderate risk of bias and no allocation concealment or intention-to-treat analyses (evident from the risk-of-bias assessment).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.2147/jpr.s542831

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Flowchart for literature search and screening.
Figure 1 Flowchart for literature search and screening.CC BY-NC · PubMed Central
Figure 2 ROB2.0 Evaluation results.
Figure 2 ROB2.0 Evaluation results.CC BY-NC · PubMed Central
Figure 3 Network plot of meta-analysis. (A) Total effective rate; (B) VAS; (C) ODI; (D) JOA; (E) IL-6; (F) TNF-α.
Figure 3 Network plot of meta-analysis. (A) Total effective rate; (B) VAS; (C) ODI; (D) JOA; (E) IL-6; (F) TNF-α.CC BY-NC · PubMed Central
Figure 4 (A) Results of network meta-analysis of Total effective rate; (B) Cumulative probability line plot of total effective rate.
Figure 4 (A) Results of network meta-analysis of Total effective rate; (B) Cumulative probability line plot of total effective rate.CC BY-NC · PubMed Central
Figure 5 (A) Results of network meta-analysis of VAS; (B) Cumulative probability line plot of VAS.
Figure 5 (A) Results of network meta-analysis of VAS; (B) Cumulative probability line plot of VAS.CC BY-NC · PubMed Central
Figure 6 (A) Results of network meta-analysis of ODI; (B) Cumulative probability line plot of ODI.
Figure 6 (A) Results of network meta-analysis of ODI; (B) Cumulative probability line plot of ODI.CC BY-NC · PubMed Central
Figure 7 (A) Results of network meta-analysis of JOA; (B) Cumulative probability line plot of JOA.
Figure 7 (A) Results of network meta-analysis of JOA; (B) Cumulative probability line plot of JOA.CC BY-NC · PubMed Central
Figure 8 (A) Results of network meta-analysis of IL-6; (B) Cumulative probability line plot of IL-6.
Figure 8 (A) Results of network meta-analysis of IL-6; (B) Cumulative probability line plot of IL-6.CC BY-NC · PubMed Central
Figure 9 (A) Results of network meta-analysis of TNF-α; (B) Cumulative probability line plot of TNF-α.
Figure 9 (A) Results of network meta-analysis of TNF-α; (B) Cumulative probability line plot of TNF-α.CC BY-NC · PubMed Central
Figure 10 Publication bias analysis funnel plots. (A) Total effective rate; (B) VAS; (C) ODI; (D) JOA; (E) IL-6; (F) TNF-α.
Figure 10 Publication bias analysis funnel plots. (A) Total effective rate; (B) VAS; (C) ODI; (D) JOA; (E) IL-6; (F) TNF-α.CC BY-NC · PubMed Central

Verification

Claims the paper makes

8 Valid · 0 Not valid · 4 Not checked · 154 Own results and interpretations

120 more claims

Create a free account to see all 166 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 23
  • Probably not a substantial claim. 28
  • The quote only partly states this claim. 4

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 32 references

Research works printed but not linked: 96

  1. Fan, 2025, Chin J Bone Joint Inj, 40, 742
  2. Liu, 2015, J Pract Tradit Chin Intern Med, 29, 23
  3. Chen, 2024, New Chin Med, 56, 112
  4. Zhang, 2023, Shaanxi J Tradit Chin Med, 44, 1141
  5. M, 2021, Shanxi Med J, 50, 1
  6. Lin, 2023, Chin J Mod Drug App, 17, 1
  7. Li, 2021, Shaanxi J Tradit Chin Med, 42, 1789
  8. Chen, 2006, Chin J Inf Tradit Chin Med, 81
  9. Xie, 2023, Mod Med Health Res, 7, 88
  10. Zhang, 2022, Chin Sci Technol J Database Med Health
  11. Shen, 2016, China Med Pharm, 6, 209
  12. Wang, 2005, Clin J Tradit Chin Med, 594
  13. Chen, 2016, World Chin Med, 11, 515
  14. Xu, 2018, Mod J Integr Tradit Chin Western Med, 27, 367
  15. Pan, 2021, Chin Foreign Med Res, 19, 26
  16. Chen, 2021, New Chin Med, 53, 145
  17. Zhou, 2016, J Pract Tradit Chin Med, 32, 72
  18. Fu, 2023, Sichuan J Physiol Sci, 45, 1220
  19. Wu, 2015, J Chengdu Univ Tradit Chin Med, 38, 43
  20. Yan, 2022, China Med Guide, 20, 129
  21. Wang, 2004, Chin J Clin Rehabil, 8, 3413
  22. Liu, 2013, Med Inf, 26, 584
  23. Zhou, 2009, Guangming J Chin Med, 24, 297
  24. Zhao, 2016, Electron J Clin Med Lit, 3, 8185
  25. Meng, 2011, Chin Med Herald, 8, 78
  26. Tian, 2018, Chin J Ethnomed Ethnopharm, 27, 105
  27. Li, 2019, Sichuan J Tradit Chin Med, 37, 196
  28. Yang, 2018, Shenzhen J Integr Tradit Chin West Med, 28, 61
  29. Li, 2016, J Nanjing Univ Tradit Chin Med, 32, 138
  30. Hou, 2017, China’s Naturopathy, 25, 1
  31. Pan, 2022, Chin Acupuncture Moxibustion, 42, 261
  32. Qian, 2019, China Health Care Nutr, 29, 68
  33. Shi, 2019, Mod Health, 133
  34. Zhao, 2023, Chin Foreign Med Res, 2, 90
  35. He, 2019, Med J Natl Defend Forces Southwest China, 29, 1016
  36. Liang, 2021, Inner Mongolia J Tradit Chin Med, 40, 121
  37. Li, 2019, Chin J Tradit Med Traumatol Orthop, 28, 992
  38. Cai, 2021, Inner Mongolia J Tradit Chin Med, 40, 88
  39. Deng, 2023, Inner Mongolia J Tradit Chin Med, 42, 141
  40. Zhao, 2024, J Clin Acupuncture Moxibustion, 40, 5
  41. Lu, 2021, Guangxi Med J, 43, 2425
  42. He, 2022, Prog Mod Biomed, 22, 1
  43. Jin, 2020, Chin J Ethnic Med, 26, 13
  44. Jin, 2022, Chin J Ethnomed Ethnopharm, 31, 105
  45. Wei, 2022, Popular Sci Technol, 24, 1
  46. Tan, 2013, Chin Foreign Med Res, 20
  47. Zhou, 2011, Jiangsu J Tradit Chin Med, 43, 62
  48. Li, 2023, Chin Foreign Med Res, 2, 87
  49. Shan, 2018, World Latest Med Inform, 18, 149
  50. Wang, 2016, World Latest Med Inform, 16, 37
  51. He, 2020, Mod Med Health Res, 4, 4
  52. An, 2021, World Healthy Living, 295, 1
  53. Zhang, 2023, Chin Sci Technol J Database Med Health, 106
  54. Deng, 2019, Diet Health, 6, 94
  55. Jia, 2018, Inner Mongolia J Tradit Chin Med, 37, 74
  56. Deng, 2023, Sichuan J Tradit Chin Med, 41, 207
  57. Yang, 2023, Diabetes Friends, 104
  58. Shi, 2023, Chin J Rural Med Pharm, 30, 11
  59. Yu, 2024, Shanghai Med Pharm J, 45, 26
  60. Yu, 2022, China Practical Med, 17, 178
  61. Deng, 2024, Health Weekly, 157
  62. Hu, 2021, Chin Med Mod Distance Educ China, 19, 55
  63. Pan, 2025, Liaoning J Tradit Chin Med, 52, 166
  64. Liu, 2024, Henan Tradit Chin Med, 44, 1606
  65. Shou, 2018, Guangxi J Tradit Chin Med, 41, 36
  66. Guan, 2021, J Hubei Univ Chin Med, 23, 90
  67. Zhang, 2013, Pract J Clin Med, 10, 85
  68. Zhu, 2022, Chin Health Stand Manag, 13, 144
  69. Ye, 2021, Chin Med Mod Distance Educ China, 19, 108
  70. Qian, 2021, Chin Sci Technol J Database Med Health, 300
  71. Wang, 2016, Guide J Tradit Chin Med Pharm, 22, 72
  72. Wang, 2016, China Practical Med, 11, 226
  73. Li, 2014, Yunnan J Trad Chin Med Mater Med, 35, 100
  74. Li, 2019, World Latest Med Inform, 19, 173
  75. Li, 2020, Electron J Clin Med Lit, 7
  76. Gu, 2020, Diet Health, 7, 96
  77. Wang, 2021, Diabetes World, 18, 187
  78. Zheng, 2019, China Health Care Nutr, 29, 155
  79. Liu, 2015, North Pharm, 12, 184
  80. Shang, 2014, J Baotou Med, 38, 222
  81. Jiang, 2018, Celebrity Doctor, 11, 1
  82. Huo, 2020, Smart Healthc, 6, 108
  83. Zhang, 2022, Heilongjiang Med J, 46, 2366
  84. Cen, 2011, Inner Mongolia J Tradit Chin Med, 30, 13
  85. Tang, 2019, Liaoning J Tradit Chin Med, 46, 1934
  86. Du, 2023, Chin J School Doctor, 37, 1
  87. Wu, 2024, Reflexol Rehabil Med, 5, 1
  88. Zhang, 2023, Diabetes World, 20, 53
  89. Wang, 2024, J Cervicodynia Lumbodynia, 45, 116
  90. Si LG, Mu R, Wu Q, Ga L, Bai L, Bao L. Efficacy evaluation of Mongolian medical warm acupuncture for sciatica caused by lumbar disc herniation: a randomized, controlled, single-blind clinical trial. Eur Rev Med Pharmacol Sci. 2024;28:2224–2236. doi:10.26355/eurrev_202403_35727 · doi:10.26355/eurrev_202403_35727
  91. Tan, 2025, Chin Arch Tradit Chin Med, 43, 220
  92. Bao, 2024, Chin J Pain Med, 30, 255
  93. Li, 2020, Contemp Med Forum, 18, 170
  94. Ling, 2020, Mod Diagn Treat, 31, 3205
  95. Spinal Pain Group SoP, Chinese Medical Association. Chinese expert consensus on the diagnosis and treatment of lumbar intervertebral disc protrusion. Chin J Pain Med. 2020;26:2–6.
  96. Zhang, 2020, J Clin Acupuncture Moxibustion, 36, 53

Metadata

Authors
Ni, D., Tong, H., Wei, S., Zheng, Y., Wu, W., Li, M., & Dong, Y.
Affiliations
Guangzhou University of Chinese Medicine (CN)
Corresponding author
Dong, Yunpeng
Venue
Journal of Pain Research
Published
2025-09
Volume
Volume 18
Pages
4809-4832
ISSN
1178-7090 (ISSN-L)
OpenAlex
W4414252374
Cited by
4
References
31
Citations by year
2026: 3 · 2025: 1
FWCI
4.93
Type
journal article
Language
en
Open access
Locations
  • Journal of Pain Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Acupuncture Treatment Research Studies
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Spine and Intervertebral Disc Pathology
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
Keywords
acupuncture, sciatica, lumbar disc herniation, electroacupuncture, cupping therapy, needle knife therapy, electrical stimulation, rehabilitation therapy, combination therapy, analgesia, disability, neurological recovery, inflammatory cytokines, interleukin-6, TNF-α

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.